Search results
Results from the WOW.Com Content Network
The Journal of Cancer is a peer-reviewed open access medical journal covering all areas of cancer research and oncology, published by Ivyspring International Publisher. The editors-in-chief are Yan-Gao Man (Bon Secours Cancer Institute) and Naoto T. Ueno (University of Texas M. D. Anderson Cancer Center).
The countries with the highest share of articles published in scientific journals according to the Nature Index 2024, which is valid for the calendar year 2023. [2] The "count" is the total number of articles to which nationals of the country have contributed.
It covers research on all aspects of cancer and cancer-related biomedical sciences and was established in 1941. The editor-in-chief is Chi Van Dang. [1] The journal was established in 1916 as the Journal of Cancer Research, was renamed American Journal of Cancer in 1931, and obtained its current name in 1941.
Cancers is a peer-reviewed, open access, medical journal published by MDPI covering all fields of oncology. [1] The editor-in-chief is Samuel C. Mok (The University of Texas MD Anderson Cancer Center). The Irish Association for Cancer Research (IACR) and the Signal Transduction Society (STS) are affiliated societies.
As of their 2022 list, Clarivate uses "performance statistics" from data in the Web of Science.There are 21 specific fields, and one for interdisciplinary science—Clarivate creates a list of papers that are in the top 1% most highly cited in their field, [a] and admission to the HCR list is based on an author's number of papers in the top 1%.
The Journal of Cancer Research and Therapeutics is a peer-reviewed open access medical journal published by Medknow Publications on behalf of the Association of Radiation Oncologists of India. The journal covers research in oncology, radiation oncology, medical imaging, radiation protection, non-ionising radiation, and radiobiology.
The journal is abstracted and indexed in: PubMed [3] Science Citation Index Expanded [4] Scopus [5] Medline [6] SCIMAGOJR [7] According to the Journal Citation Reports, the journal has a 2021 impact factor of 69.800, ranking it 2nd out of 245 journals in the category "Oncology". [8]
Li-Kuo Su became Editor-in-Chief in 2003 and is recognized for promoting the journal's growth and establishing it as one of the most reputable cancer research journals. He retired from his editorial activities in 2019. Steve Mao became Cancer Cell 's Editor-in-Chief in 2020 after serving as senior editor at Cell and Science.